INVO Fertility EPS IVF
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $0.35
- Fiscal year 2024
- −$3390.00
INVO Fertility's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $0.35.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2024 | −$3390.00 | n/a |
| FY2023 | −$12240.00 | n/a |
| FY2022 | −$25862.40 | n/a |
| FY2021 | −$19296.00 | n/a |
| FY2020 | −$41760.00 | n/a |
| FY2019 | −$10310.40 | n/a |
| FY2018 | −$18432.00 | n/a |
| FY2017 | $0.00 | n/a |
| FY2016 | −$9216.00 | n/a |
| FY2015 | −$36864.00 | n/a |
| FY2014 | n/a | n/a |
| FY2013 | n/a | n/a |
| FY2012 | n/a | n/a |
| FY2011 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.35 | n/a | n/a | |
| Q1 FY26 | −$3.38 | n/a | n/a | |
| Q3 FY25 | −$30.80 | n/a | −$4852.96 | |
| Q2 FY25 | −$364.23 | n/a | −$5426.56 | |
| Q1 FY25 | −$3473.93 | n/a | −$5957.93 | |
| Q4 FY24 | −$984.00 | n/a | −$3390.00 | |
| Q3 FY24 | −$604.40 | n/a | −$3327.60 | |
| Q2 FY24 | −$895.60 | n/a | −$3731.20 | |
| Q1 FY24 | −$906.00 | n/a | −$7242.00 | |
| Q4 FY23 | −$921.60 | n/a | −$12240.00 | |
| Q3 FY23 | −$1008.00 | n/a | −$17870.40 | |
| Q2 FY23 | −$4406.40 | n/a | −$22896.00 |
Against its peers
Companies in Healthcare nearest INVO Fertility's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| IVFINVO Fertility | n/m | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| Peer median | $0.19 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on INVO Fertility
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.